Fukushima Norihide, Miyamoto Yuji, Ohtake Shigeaki, Sawa Yoshiki, Takahashi Toshiki, Nishimura Motonobu
Division of Cardiovascular Surgery, Department of Surgery, Osaka University Graduate School of Medicine, Osaka, Japan.
Asian Cardiovasc Thorac Ann. 2004 Jun;12(2):154-8. doi: 10.1177/021849230401200215.
Since the new organ transplantation law was established in 1997, 17 heart transplantations have been performed in Japan, 7 of which were carried out at Osaka University Hospital. Recipient diagnosis was dilated cardiomyopathy in 2, dilated phase of hypertrophic cardiomyopathy in 4, and post-myocarditis cardiomyopathy in 1. Ages ranged from 8 to 49 years with a mean of 35.3 years. Five patients were bridged with a left ventricular assist device. The waiting period was 182-977 days (mean, 643 days). There was no early or late death during follow-up of 1-4.8 years. Under a standard triple-drug regimen using mycophenolate, there were 3 rejection episodes greater than grade 3 in 2 patients, and humoral rejection requiring plasmapheresis in one. A young boy whose donor was a hemodynamically compromised adult developed neurological sequelae after resuscitation following ventricular tachycardia. All patients were discharged and went back to work or their regular daily life. Although the donor shortage is still severe in Japan, the resumption of heart transplantation has been satisfactory, and left ventricular assist devices have played a crucial role.
自1997年新的器官移植法颁布以来,日本已进行了17例心脏移植手术,其中7例在大阪大学医院实施。接受者的诊断结果为:2例为扩张型心肌病,4例为肥厚型心肌病的扩张期,1例为心肌炎后心肌病。年龄范围为8至49岁,平均年龄为35.3岁。5例患者使用左心室辅助装置作为过渡。等待时间为182 - 977天(平均643天)。在1至4.8年的随访期间无早期或晚期死亡病例。在使用霉酚酸酯的标准三联药物治疗方案下,2例患者发生3级以上排斥反应3次,1例发生需要血浆置换的体液排斥反应。一名供体为血流动力学不稳定成年人的小男孩在室性心动过速复苏后出现神经后遗症。所有患者均已出院并恢复工作或正常日常生活。尽管日本的供体短缺问题仍然严峻,但心脏移植手术的恢复情况令人满意,左心室辅助装置发挥了关键作用。